Search

Objective To explore the Influence for prognosis of patients with asymptomatic catheter-related thrombosis (CRT) without anticoagulation therapy. Methods The clinical data of 357 adult asymptomatic CRT patients admitted to the hospital from September 2017 to January 2019 were retrospectively analyzed, including age, thrombus volume, D-dimer level, ultrasound results, complications and follow-up. The thrombus volume and D-dimer level of at the time of diagnosis and before catheter removal were statistically compared. Results Among the 357 patients, 43 patients pulled out the catheter when asymptomatic CRT was diagnosed. In the remaining 314 patients, asymptomatic pulmonary embolism was accidentally found in 1 patient, catheter-related blood flow infection occurred in 5 patients, and catheter blockage occurred in 3 patients. The thrombus volume and D-dimer levels of the resting 302 patients without anticoagulant therapy were significantly lower than those at the time of diagnosis, the differences were statistically significant (P <0. 05). 3 months after extubation, no follow-up patient developed obvious post-deep vein thrombosis syndrome. Conclusion After the occurrence of CRT, the thrombus volume and D-dimer level of patients without anticoagulant trerapy can decrease spontaneously, and there is no obvious adverse effect on the prognosis of patients. [ABSTRACT FROM AUTHOR]

Maintenance hemodialysis is one of the renal replacement therapy that end-stage renal disease patients mainly rely on. Dyskalemia is one of the most common metabolic complications in patients undergoing maintenance hemodialysis. Both predialysis hyperkalemia and hypokalemia during and after dialysis may contribute to a higher risk of all-cause mortality, cardiovascular mortality in hemodialysis patients. The impact of serum potassium fluctuation has attracted widespread attention in recent years. Due to the intermittent nature of maintenance hemodialysis, patients are prone to frequent fluctuations of serum potassium. Potassium variability may be a better indicator to reflect potassium homeostasis, and large variability of potassiun is recognized as a potential risk factor for poor outcomes. In addition, the rapid fluctuation of serum potassium concentration during hemodialysis may increase the risk of malignant arrhythmia, sudden cardiac death and other poor outcomes. The gradient of serum and dialysate potassium is an important factor that influence the removal of potassium, which is also affected by other dialysate components. Therefore, strengthening the monitoring and management of serum potassium, selecting appropriate dialysate potassium concentration and individualizing dialysate prescription may be beneficial to maintain potassium homeostasis, reduce dyskalemia and improve prognosis. This review briefly expounds the feature of serum potassium level and discusses its effect on outcomes in patients with maintenance hemodialysis, emphasizing the relevance of potassium variation and prognosis in patients with maintenance hemodialysis and the impact of dialysate composition on potassium homeostasis. [ABSTRACT FROM AUTHOR]

Acquired cystic disease-associated renal cell carcinoma (ACD-RCC) is the most common type of RCC seen in patients with end-stage renal disease and acquired cystic kidney disease, and was added to the list of RCC subtypes in the 2016 World Health Organization classification. ACD-RCC is generally believed to be indolent, however, some tumors may show local recurrence and distant metastasis. Periodic screening should be performed in dialysis patients, especially in younger patients with minor comorbidities, early detection and early intervention can improve the prognosis and quality of life. Literatures published at home and abroad mainly focused on it's clinicopathological features, there is scarce research describing the imaging appearance, prognosis and surveillance of ACD-RCC. This paper summarizes the epidemiology, etiology, pathological features, imaging manifestations, treatment, prognosis and surveillance ofACD-RCC, and aims to provide a compressive understanding of the disease for clinicians. [ABSTRACT FROM AUTHOR]

Objective: To analyze the clinical characteristics, treatment and influencing factors of prognosis of newly diagnosed young patients with medium/high risk diffuse large B cell lymphoma(DLBCL). Methods: The clinical data of young(≤60years)age-adjusted international Prognostic Index(aa IPI) score of 2 or 3 patients with DLBCL were collected. These patients were initially diagnosed and treated in Academy of Military Medical Sciences from January 2006 to May 2014. The efficacy and influencing factors of prognosis were evaluated. Results: A total of 120 DLBCL patients were included in this retrospective analysis. After a median follow-up of 28 months, the estimated progression-free survival(PFS) and overall survival(OS) at three years were 53.25% and 61.52%. In univariate analysis, B symptoms, regimen and therapeutic effect, ASCT had significant influence on PFS and OS. In multivariate analysis,regimen and therapeutic effect and ASCT were independent risk factors associated with PFS, OS. Conclusions: Young patients with medium/high risk diffuse large B cell lymphoma is a heterogeneous entity, immunological subtypes and Ki-67 index were not related to survival, but this result is not conclusive until these factors are further tested. [ABSTRACT FROM AUTHOR]